Screener
Bausch Health Companies BHC EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Bausch Health Companies’s reported figures.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
FAQ
- What is Bausch Health Companies's EBITDA?
- Bausch Health Companies (BHC) reported EBITDA of -$655M in Q1 2026.
- How has Bausch Health Companies's EBITDA changed year-over-year?
- Bausch Health Companies's EBITDA decreased by 212.7% year-over-year, from $581M to -$655M.
- What is the long-term trend for Bausch Health Companies's EBITDA?
- Over 4 years (2021 to 2025), Bausch Health Companies's EBITDA has grown at a 10.8% compound annual growth rate (CAGR), from $2B to $3.02B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Bausch Health Companies's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude